GlassScriptPhysician profile
John Matthew Conoyer
NPI 1881875961
$1,347.43
in general payments reported to CMS, 2019-2025
15 companies · $262 in 2025
The $262 reported for 2025 was less than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $202 · 2020: $235 · 2021: $15.03 · 2022: $267 · 2023: $306 · 2024: $59.71 · 2025: $262.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $628.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $627.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $472.00 | 2019-2025 | Audion Et Dilation System, Clarifix, Xpress Loprofile |
| Aerin Medical INC. | $252.05 | 2020-2023 | |
| Acclarent, INC | $171.48 | 2019-2023 | Trudi Nav Cable, Relieva Spinplus, Acclarent Aera |
| Intersect Ent, INC. | $84.08 | 2020-2021 | |
| Smith+Nephew, INC. | $58.85 | 2020-2023 | Rf20000 |
| Medtronic, INC. | $57.64 | 2024-2025 | Propel |
| Karl Storz Endoscopy-America | $47.91 | 2019 | |
| Ethicon US, LLC | $44.08 | 2023 | Ethicon, Surgiflo Hemostatic Matrix, Vistaseal |
| Novartis Pharmaceuticals Corporation | $36.48 | 2019-2020 | |
| Glaxosmithkline, LLC. | $33.60 | 2022 | |
| Integra Lifesciences Corporation | $27.50 | 2025 | Inspira Air, Acclarent Aera, Trudi Probe |
| Itamar Medical INC | $23.07 | 2024 | Watchpatone |
| Bolder Surgical, LLC | $14.95 | 2022 | |
| Davol INC. | $12.82 | 2023 | Arista Ah Flexitip |
| Misonix INC | $10.92 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Conoyer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.